Why Choose ThinWorks for BPC-157 Peptide Therapy
For laboratory research use only not for human consumption
doi: 10.1111/jch.13737 49
Injectable BPC-157: Higher Absorption and Targeted Repair Typical range: 2001,000 mcg per day Common dose: 500 mcg per day Method: Subcutaneous (SubQ) injection near the injury site or abdomen Cycle: 26 weeks depending on injury severity Injectable BPC-157 offers the highest bioavailability and fastest results, especially for tendon, ligament, and muscle injuries
Pre-Treatment Guidelines Baseline metabolic panel, fasting glucose, lipid profile, blood pressure monitoring
Off-label veterinary use and animal studies indicate that it is in general well tolerated, although it is not FDA approved for dogs , and should only be used under veterinary supervision